IFNA2 Antikörper (N-Term)
-
- Target Alle IFNA2 Antikörper anzeigen
- IFNA2 (Interferon, alpha 2 (IFNA2))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IFNA2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC)
- Spezifität
- Interferon alpha 2 Antibody detects endogenous levels of total Interferon alpha 2.
- Homologie
- Horse
- Aufreinigung
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human Interferon alpha 2, corresponding to a region within N-terminal amino acids.
- Isotyp
- IgG
- Top Product
- Discover our top product IFNA2 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Haltbarkeit
- 12 months
-
- Target
- IFNA2 (Interferon, alpha 2 (IFNA2))
- Andere Bezeichnung
- IFNA2 (IFNA2 Produkte)
- Synonyme
- IFN-alphaA antikoerper, IFNA antikoerper, IFNA2B antikoerper, INFA2 antikoerper, Ifa2 antikoerper, IFNA2 antikoerper, interferon alpha 2 antikoerper, interferon, alpha 2 antikoerper, interferon-alpha-2 antikoerper, interferon alpha-2 antikoerper, IFNA2 antikoerper, Ifna2 antikoerper, ifna2 antikoerper, IFN-ALPHA2 antikoerper, LOC102142148 antikoerper
- Hintergrund
-
Description: Produced by macrophages, IFN-alpha have antiviral activities.
Gene: IFNA2
- Gen-ID
- 3440
- UniProt
- P01563
- Pathways
- JAK-STAT Signalweg, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
-